Nasdaq Agle News Today

StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a report released on Saturday morning. The firm issued a sell rating on the biotechnology company’s stock. Aeglea BioTherapeutics Stock Performance The stock has a market cap of $48.64 million, a PE ratio of -0.16 and a beta of 2.57. The company […]

StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Wells Fargo & Company increased their target price on shares of Aeglea BioTherapeutics from $8.75 to $12.50 and gave the stock an equal weight […]

Aeglea BioTherapeutics (NASDAQ:AGLE – Get Free Report) is scheduled to issue its quarterly earnings data on Wednesday, November 1st. Aeglea BioTherapeutics (NASDAQ:AGLE – Get Free Report) last posted its earnings results on Friday, August 11th. The biotechnology company reported ($41.50) EPS for the quarter, missing analysts’ consensus estimates of ($4.50) by ($37.00). The company had […]

StockNews.com downgraded shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) from a hold rating to a sell rating in a research note published on Tuesday morning. Several other research firms have also commented on AGLE. Stifel Nicolaus started coverage on shares of Aeglea BioTherapeutics in a report on Tuesday, July 25th. They issued a buy […]

StockNews.com cut shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) from a hold rating to a sell rating in a research report released on Tuesday morning. Several other research analysts have also weighed in on the stock. Stifel Nicolaus assumed coverage on shares of Aeglea BioTherapeutics in a report on Tuesday, July 25th. They set […]

StockNews.com upgraded shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) from a sell rating to a hold rating in a research report report published on Saturday morning. Several other equities analysts have also recently weighed in on AGLE. Stifel Nicolaus assumed coverage on shares of Aeglea BioTherapeutics in a research note on Tuesday, July 25th. […]

Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE – Get Free Report) was the recipient of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 1,570,000 shares, a decrease of 26.3% from the July 31st total of 2,130,000 shares. Based on an average daily trading volume, of 6,290,000 […]

StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a research report sent to investors on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities research analysts have also issued reports on AGLE. Stifel Nicolaus started coverage on Aeglea BioTherapeutics in a report on […]

StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a research report report published on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. AGLE has been the subject of several other research reports. Wells Fargo & Company boosted their target price on shares of Aeglea BioTherapeutics […]

StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a research report released on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Stifel Nicolaus began coverage on Aeglea BioTherapeutics in a research note on Tuesday, July 25th. They set a buy rating and a $0.90 […]